Skip to main content
logo
Acro Biomedical Co., Ltd. (ACBM)
OTCMKTS · Delayed Price · Currency is USD
0.0260
0.00 (0.00%)
At close: Jun 16, 2026

Acro Biomedical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.661.2
Revenue Growth
-----45.01%74.06%
Gross Profit
----0.140.26
Operating Income
-0.21-0.15-0.04-8.79-15.87-7.69
Net Income
-0.13-0.1-0.04-8.81-15.87-7.7
Earnings Per Share
-0.00-0.00-0.00-0.15-0.26-0.14
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
00000.010.1
Total Debt
0.380.330.150.140.10.07
Net Cash (Debt)
-0.37-0.32-0.15-0.14-0.10.02
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.00-0.00-0.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.22-0.2-0.04-0.02-0.150.3
Free Cash Flow
-0.22-0.2-0.04-0.02-0.150.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----21.34%21.67%
Operating Margin
-----2409.98%-642.47%
Pretax Margin
-----2410.24%-642.82%
Profit Margin
-----2410.24%-642.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----410.31233.15